XML 17 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) Statements - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Cash flows from operating activities:    
Net income $ 25,880 $ 38,390
Adjustments to reconcile net income to net cash used in operating activities:    
Depreciation and amortization 4,319 4,157
Deferred taxes 15,630 0
Share-based compensation 3,218 2,194
Gain on disposal of long-lived assets and deferred gain amortization (34) (270)
Unrealized losses on foreign currency forward contracts 3,111 0
Change in assets and liabilities:    
Accounts receivable, net (106,254) (114,973)
Inventories 20,410 25,625
Other assets (1,565) (2,821)
Accounts payable and accrued expenses (17,692) (11,793)
Accrued employee compensation and benefits (8,037) (11,641)
Accrued warranty expense 550 644
Income taxes receivable/payable (2,326) (718)
Other liabilities (15) (253)
Net cash used in operating activities (62,805) (71,459)
Cash flows from investing activities:    
Acquisitions, net of cash acquired (58,629) 0
Capital expenditures (6,301) (4,963)
Proceeds from sales of property and equipment 38 6
Collection of note receivable 0 3,104
Investment in golf-related ventures 0 (1,260)
Net cash used in investing activities (64,892) (3,113)
Cash flows from financing activities:    
Proceeds from asset-based credit facilities, net 64,988 64,000
Acquisition of treasury stock (15,369) (2,878)
Dividends paid (939) (941)
Exercise of stock options 484 384
Net cash provided by financing activities 49,164 60,565
Effect of exchange rate changes on cash and cash equivalents 547 (658)
Net decrease in cash and cash equivalents (77,986) (14,665)
Cash and cash equivalents at beginning of period 125,975  
Cash and cash equivalents at end of period 47,989 35,136
Supplemental disclosures:    
Cash paid for income taxes, net 4,460 2,122
Cash paid for interest and fees 494 527
Noncash investing and financing activities:    
Issuance of treasury stock for compensatory stock awards released from restriction 3,099 0
Accrued capital expenditures at period-end $ 1,267 $ 793